Brett Leav

MedicineImmunology and MicrobiologyAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination”.

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

New England Journal of Medicine(2020)10.1056/nejmc2032195

N/A

18.5DataRank · unranked

831 citations

Nadine Rouphael, Lisa A. Jackson, Evan J. Anderson, Paul C. Roberts, Mamodikoe Makhene +26 more

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

New England Journal of Medicine(2021)10.1056/nejmoa2113017

N/A

8.3DataRank · unranked

662 citations

Lindsey R. Baden, Brandon Essink, Susanne Doblecki‐Lewis, Judith M. Martin, Evan J. Anderson +33 more

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

New England Journal of Medicine(2020)10.1056/nejmoa2028436

N/A

1.1DataRank · unranked

1633 citations

Nadine Rouphael, Alicia T. Widge, Lisa A. Jackson, Paul C. Roberts, Mamodikoe Makhene +32 more

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac188

N/A

0.686DataRank · unranked

21 citations

Lindsey R. Baden, Brandon Essink, David C. Montefiori, Adrian McDermont, Richard Rupp +19 more

Risk of COVID-19 after natural infection or vaccination

EBioMedicine(2023)10.1016/j.ebiom.2023.104799

N/A

0.396DataRank · unranked

13 citations

Matthew B. Laurens, Ying Huang, Chenchen Yu, Thomas Martin, Carina A. Rodriguez +94 more

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

New England Journal of Medicine(2021)10.1056/nejmc2103916

N/A

0DataRank · unranked

758 citations

Mehul S. Suthar, Mat Makowski, Sarah O’Connell, Adrian B. McDermott, Britta Flach +25 more

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)

Vaccine(2022)10.1016/j.vaccine.2022.06.005

N/A

0DataRank · unranked

8 citations

Walter L. Straus, P. White, Alison Leav, Tashawnee Gaines, Grace Maggiacomo +5 more

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.13.444010

N/A

0DataRank · unranked

54 citations

Sarah O’Connell, Stephen D. Schmidt, Sijy O’Dell, Chloe Adrienna Talana, Lilin Lai +27 more

COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials

Clinical Infectious Diseases(2024)10.1093/cid/ciae192

N/A

0DataRank · unranked

6 citations

Jessica Tuan, Valeria D Cantos, Oladunni Adeyiga, Scott Mahoney, Ana M. Ortega‐Villa +25 more

A Phase I/II Randomized Trial of Higher Dose mRNA-1273 Boosters in Lung Transplant Recipients

OBM Transplantation(2024)10.21926/obm.transplant.2404227

N/A

0DataRank · unranked

0 citations

F. Javier Ibarrondo, Jesse L. Clark, Adreanne Rivera, Marlene Florian, Allison Ramsey +25 more

Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial

International Journal of Infectious Diseases(2023)10.1016/j.ijid.2023.09.012

N/A

0DataRank · unranked

14 citations

Xiaoying Shen, Lindsay N. Carpp, David Benkeser, Dean Follmann, Holly Janes +8 more